Superior bioavailability of EPA and DHA from a L-lysine salt formulation: a randomized, three-way crossover study
The study demonstrates that EPA and DHA lysine salt (Lys-FFA) offers superior bioavailability compared to EE and triglyceride forms, presenting a more effective supplementation option.German Clinical Trials Register, DRKS-ID: DRKS00029183.
Authors
- Antje Micka
- Christiane Schön
- Vishnupriya Gourineni
- Roberta Bosi
Institutions
- Evonik (Germany) (DE)
- Enzon Pharmaceuticals (United States) (US)
- BioTeSys (Germany) (DE)
Publication Details
- Journal
- Food & Nutrition Research
- Published
- 2024-12-27
- DOI
- https://doi.org/10.29219/fnr.v68.11028
- Primary Topic
- Fatty Acid Research and Health
- Type
- article
- Field-Weighted Citation Impact
- 0.00